Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update
G Sartore, E Ragazzi, R Caprino, A Lapolla - Acta diabetologica, 2023 - Springer
Aims The aim of the present study was to evaluate, by means of a meta-analysis approach,
whether new available data, appeared on qualified literature, can support the effectiveness …
whether new available data, appeared on qualified literature, can support the effectiveness …
Wearable and digital devices to monitor and treat metabolic diseases
Cardiometabolic diseases are a major public-health concern owing to their increasing
prevalence worldwide. These diseases are characterized by a high degree of interindividual …
prevalence worldwide. These diseases are characterized by a high degree of interindividual …
Sodium-glucose cotransporter 2 (SGLT2) inhibitors vs. dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset dementia: a propensity score-matched population …
Introduction: The effects of sodium-glucose cotransporter 2 inhibitors (SGLT2I) and
dipeptidyl peptidase-4 inhibitors (DPP4I) on new-onset cognitive dysfunction in type 2 …
dipeptidyl peptidase-4 inhibitors (DPP4I) on new-onset cognitive dysfunction in type 2 …
Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
Introduction Recent studies have reported that HbA1c and lipid variability is useful for risk
stratification in diabetes mellitus. The present study evaluated the predictive value of the …
stratification in diabetes mellitus. The present study evaluated the predictive value of the …
Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics, and function through the PPAR-γ/PGC …
Z Zhang, X Zhang, L Meng, M Gong, J Li… - Frontiers in …, 2021 - frontiersin.org
Background: Oxidative stress contributes to adverse atrial remodeling in diabetes mellitus.
This remodeling can be prevented by the PPAR-γ agonist pioglitazone via its antioxidant …
This remodeling can be prevented by the PPAR-γ agonist pioglitazone via its antioxidant …
HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
Background HbA1c variability has emerged as risk factor for cardiovascular diseases in
diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects …
diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects …
Comparison of sodium-glucose cotransporter-2 inhibitor and dipeptidyl peptidase-4 inhibitor on the risks of new-onset atrial fibrillation, stroke and mortality in diabetic …
Objective To compare the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2Is) and
dipeptidyl peptidase-4 inhibitors (DPP4Is) on adverse outcomes in diabetic patients in Hong …
dipeptidyl peptidase-4 inhibitors (DPP4Is) on adverse outcomes in diabetic patients in Hong …
Diabetes knowledge predicts HbA1c levels of people with type 2 diabetes mellitus in rural China: a ten-month follow-up study
X Wang, B Tian, S Zhang, J Zhang, W Yang, J Li… - Scientific Reports, 2023 - nature.com
Improving diabetes self-management (DSM) is facing real-world challenges among people
with type 2 diabetes mellitus (T2DM) who have a low education level in resource-limited …
with type 2 diabetes mellitus (T2DM) who have a low education level in resource-limited …
[HTML][HTML] Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus
TE Wu, YW Su, HS Chen - Diabetes research and clinical practice, 2022 - Elsevier
Aims To study the different effects of mean HbA1c and HbA1c variability on diabetes-related
complications in patients with type 2 diabetes mellitus. Methods 1869 patients with type 2 …
complications in patients with type 2 diabetes mellitus. Methods 1869 patients with type 2 …
Risk of new-onset prostate cancer for metformin versus sulfonylurea use in type 2 diabetes mellitus: a propensity score–matched study
Background: The aim of this study was to compare the risks of new-onset prostate cancer
between metformin and sulfonylurea users with type 2 diabetes mellitus (T2DM). Methods …
between metformin and sulfonylurea users with type 2 diabetes mellitus (T2DM). Methods …